BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roofthooft MT, van Loon RL, Berger RM. Management of pulmonary arterial hypertension in children. Paediatr Respir Rev. 2010;11:240-245. [PMID: 21109183 DOI: 10.1016/j.prrv.2010.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Sabri MR, Beheshtian E. Comparison of the therapeutic and side effects of tadalafil and sildenafil in children and adolescents with pulmonary arterial hypertension. Pediatr Cardiol 2014;35:699-704. [PMID: 24253611 DOI: 10.1007/s00246-013-0840-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
3 Dickinson MG, Bartelds B, Borgdorff MA, Berger RM. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models. Am J Physiol Lung Cell Mol Physiol 2013;305:L1-14. [PMID: 23624788 DOI: 10.1152/ajplung.00031.2013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
4 Kyle WB. Pulmonary Hypertension Associated with Congenital Heart Disease: A Practical Review for the Pediatric Cardiologist: Pulmonary Hypertension: A Practical Review. Congenit Heart Dis 2012;7:575-83. [DOI: 10.1111/chd.12012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]